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Abstract
Background: Cancer registries systematically collect cancer-related data to support cancer surveillance activities. However,
cancer data are often unavailable for months to years after diagnosis, limiting its utility.
Objective: The objective of this study was to identify the barriers to rapid cancer reporting and identify ways to shorten the
turnaround time.
Methods: Certified cancer registrars reporting to the Indiana State Department of Health cancer registry participated in a
semistructured interview. Registrars were asked to describe the reporting process, estimate the duration of each step, and identify
any barriers that may impact the reporting speed. Qualitative data analysis was performed with the intent of generating
recommendations for workflow redesign. The existing and redesigned workflows were simulated for comparison.
Results: Barriers to rapid reporting included access to medical records from multiple facilities and the waiting period from
diagnosis to treatment. The redesigned workflow focused on facilitating data sharing between registrars and applying a more
efficient queuing technique while registrars await the delivery of treatment. The simulation results demonstrated that our
recommendations to reduce the waiting period and share information could potentially improve the average reporting speed by
87 days.
Conclusions: Knowing the time elapsing at each step within the reporting process helps in prioritizing the needs and estimating
the impact of future interventions. Where some previous studies focused on automating some of the cancer reporting activities,
we anticipate much shorter reporting by leveraging health information technologies to target this waiting period.
(JMIR Cancer 2018;4(1):e4)   doi:10.2196/cancer.7515
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Introduction
Data Quality in Cancer Registries
Despite multiple reports from the National Academy of
Medicine (NAM; formerly Institute of Medicine) dating back
to 1999, achieving higher quality cancer care remains a
challenge [1]. In its latest report, the NAM recommended
leveraging health information technologies to create a Rapid
Learning System in which the latest evidence and knowledge
regarding cancer case outcomes is fed back into cancer care
delivery processes and treatments [1]. One specific
recommendation is to leverage cancer registries together with
electronic health record (EHR) systems to enable timely capture
and reporting of data [2,3]. Current approaches can take more
than a year after diagnosis before data are available at
state-based cancer registries for wider use [4]. Despite the rich
data available in cancer registries, the lengthy reporting time
poses a major barrier to using these data for real-time, actionable
outcome and quality reports [1-5].
Understanding Cancer Reporting Process
There is limited evidence on the reporting process, the barriers
to more rapid reporting, or precisely how EHR systems might
be used to improve timeliness. Existing studies largely examine
factors associated with the timeliness of cancer data [6-10]. For
example, a study in the first group by Gagen and Cress
investigated the association between reporting delays and
gender, race, type of reporting facility, cancer site, and stage at
diagnosis [10]. Of these factors, the type of reporting facility
(eg, hospital, physician’s office, and laboratory) was associated
with reporting time; cases reported by hospitals had shorter
reporting times compared with those reported by physician
offices or laboratory centers [10]. At least one prior study
focused on EHR systems’ impact on cancer registries. Among
a convenience sample of cancer registrars, Houser et al asked
attendees at a conference whether they used EHR systems to
access data, as well as their perceptions of the benefits and
challenges associated with EHR usage [11]. Although this study
found that EHR systems were being used and viewed favorably
by the majority of sampled conference attendees, the study did
not provide detailed insights into the sequence of reporting tasks
or the workflow efficiency.
While providing an important foundation, prior research has
not described the precise challenges associated with the sequence
of steps involved in the cancer reporting process or potential
solutions to address specific challenges. Cancer reporting is
complex, labor-intensive, and typically performed by certified
cancer registrars referred to as certified tumor registrars (CTRs).
Registrars are data information specialists who capture the
complete medical history for cancer patients including diagnosis,
treatment, and health status and then report this information to
cancer registries [12]. Cancer registrars must compile patient
data from various sources, analyze these data, and enter the data
into a complete, uniform abstract. These abstracts must then be
transmitted along a reporting chain spanning hospitals, state
health agencies, and the national Centers for Disease Control
and Prevention (CDC). Reporting turnaround time is largely
dependent upon the activities performed at the hospital level by
cancer registrars such as data searching, collection, and
abstraction. Reduction in the reporting time cannot be achieved
without a comprehensive understanding of the reporting
workflow and challenges faced by CTRs at the hospital level.
To address similar challenges, many studies have shown the
value of workflow evaluation in navigating the complexity of
health care systems. Workflow evaluation has been used in
health care settings such as emergency departments, primary
care, pharmacy, and radiology departments [13-17]. These
studies commonly utilize some combination of field observations
and in-depth interviews. Although field observations can reveal
details that users might overlook, in-depth interviews can
provide a deeper understanding of the processes and tasks
involved, such as task descriptions, alternative routes, the
rationale for given choices, and the difficulties encountered.
To investigate the reporting process and identify barriers to
timely reporting, we conducted key informant interviews with
CTRs across the state of Indiana. Insights from the interviews
were translated into input for simulations of the reporting
process to explore ways that the reporting time could be
decreased. In addition, the study explored ways in which EHR
systems and health information exchange (HIE) could be
leveraged to improve cancer reporting data timeliness.
Methods
Study Design
To better understand the complex processes involved in cancer
case reporting, we conducted a multi-phase study. First, we
interviewed cancer registrars to identify barriers to timely
reporting and developed a model of current reporting processes.
Second, we developed computer simulation models to represent
the current state and a potential, redesigned future state. The
outputs of the two simulations were compared to determine the
impact of health information technology innovations, including
the use of EHR systems that might be implemented to increase
the speed of cancer case reporting processes. The study was
approved by the institutional review board at Indiana University.
System and Scope
In the United States, all 50 individual states have programs for
cancer surveillance, involving the routine collection and
compilation of specified clinical and demographic information
about every newly diagnosed, reportable cancer [18,19].
Hospitals report cancer cases to state-level registries operated
by public health authorities, which in turn report to nationwide
registries to enable population-based analysis. Cases received
by state registries are reported to the Surveillance,
Epidemiology, and End Results program operated by the
National Cancer Institute and/or the National Program of Cancer
Registries operated by the CDC [18-23].
In this study, we examine the US state-level cancer reporting
process by interviewing CTRs who report on behalf of hospitals
to the Indiana State Department of Health (ISDH) cancer
registry. The ISDH cancer registry collects information related
to tumor cases diagnosed or treated within the State of Indiana
as required by state law or federal regulations [22].
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The information obtained by the ISDH cancer registry includes
demographic, treatment, and diagnostic data that are used for a
wide range of activities, including epidemiologic studies of
cancer causes and outcomes that can inform public health
policies [22].
Study Participants and Recruitment
In this study, recruitment was limited to CTRs who report case
information to the ISDH cancer registry. Participants were
invited to participate in either face-to-face or telephone
interviews. Participants were identified through hospital staff
directories and the Indiana Cancer Registrars Association. When
recruiting participants, we directly contacted registrars reporting
for larger hospitals (with 300 beds or more) within Indianapolis.
To include registrars reporting for smaller hospitals and
individual facilities, registrars from the Indiana Cancer
Registrars Association directory were invited via email.
Nonrespondents were reminded 2 weeks after the initial
invitation. Snowball sampling, wherein initial contacts identify
other individuals who may have insight into the topics of
interest, was also used to expand the number of participants.
Recruitment occurred over a 5-month period between the end
of March and August 2015. The recruitment process was
concurrent with the development of the workflow and simulation
models to validate model assumptions and compare the
simulation output with the real system. Participants were
identified and approached until saturation was achieved [24],
that is, until no new themes or ideas were found. Upon
completion of the interview, participants were thanked with a
US $20 gift card.
Interview Guide
Interviews were semistructured and task-oriented. The interview
guide was developed to investigate the following areas: (1)
understanding the workflow of cancer reporting, (2) estimating
the time spent on each phase within the process, and (3)
identifying the barriers to rapid reporting (Multimedia Appendix
1). Follow-up questions were asked for clarification and to
confirm the representation of the developed model. Probing
questions were asked to investigate additional information such
as decision-making processes and alternative processes. For
example, participants were asked to estimate the time required
to complete abstraction of case information from the patient’s
record. Later, they were asked if there are any types of
information that take longer than others to abstract, and if so,
how often they encounter these data types. In addition to
describing the present state of cancer registry reporting,
participants were asked to freely envision and describe optimal
cancer reporting mechanisms, enabling them to transcend
concerns for current resources or structural limitations [25].
Analysis
Interview data were analyzed using a grounded theory approach
[26-28]. We employed the following analysis steps: open coding,
axial coding, and selective coding [26]. During the open coding
step, keywords, phrases, and ideas were extracted to develop
concepts and subcategories. Examples of these subcategories
included barriers, facilitators, duration of each subtask, and
reporting sources. During the axial coding, we grouped the
concepts and subcategories into similar categories and
considered the relationships among them. One relationship
included the reporting step in which a barrier was encountered
and a facilitator was used to overcome the barrier. For example,
when CTRs reported difficulties accessing information from
external hospitals, we examined whether the difficulties were
encountered during the case finding or the abstracting phase.
We further examined whether a barrier was encountered for all
cancer types or a particular type of cancer, as well as whether
a barrier was reported by CTRs from all hospitals or a subgroup
of hospitals (eg, large hospitals). During selective coding, we
used the derived categories to form higher-level themes. The
analysis was performed using NVivo 10 (developed by QSR
international).
Flowchart and Simulation Development
Data from the interviews were utilized to guide the development
and refinement of information flow models. We identified
sequences of reporting activities, data sources, roles, and the
duration of each task. The procedure for the flowchart
development followed the hierarchical task analysis technique
[29]. The flowchart developed arranges the tasks within the
reporting process and the flow of information for both the
existing workflow (Figure 1) and the redesigned workflow
(Figure 2).
Using AnyLogic 7.1, we developed a discrete-events simulation
of the current workflow (Figure 3). We used the data collected
during the interviews to inform the simulation development
(Multimedia Appendix 2). The input data included the duration
of activity, waiting time, and number of cases performed. The
simulation model provided an indication of the time spent at
each phase of reporting (eg, processing time, waiting time, and
time cases spend in queue before being processed). The
flowchart and simulation model development occurred
concurrently with the interviews to test the model’s assumptions
and enable iteration. This allowed us to validate the model
representation and assumptions with the data obtained from the
interviewees.
The simulation model was validated through an iterative process
of calibration and comparison with the existing workflow. This
validation included ensuring the model represented real-life
processes by comparing the total reporting time estimated by
the registrars in interviews with the simulation output [30].
JMIR Cancer 2018 | vol. 4 | iss. 1 | e4 | p.3http://cancer.jmir.org/2018/1/e4/
(page number not for citation purposes)
Jabour et alJMIR CANCER
XSL•FO
RenderX
Figure 1. Cancer reporting flowchart for the existing workflow. ICD: International Classification of Diseases.
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Figure 2. Cancer reporting flowchart for the redesigned workflow. ICD: International Classification of Diseases.
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Figure 3. Simulation model for the existing workflow.
Thereafter, we simulated the redesigned workflow to estimate
the difference in reporting time compared with the current
workflow (Figure 4). In the existing workflow, registrars wait
about 3-6 months for treatment to be initiated (Textbox 1). To
predict the potential savings in reporting time, we needed to
estimate the time between diagnoses and receiving treatment,
which could not be estimated by the interviewed registrars.
Registrars agreed that this time could vary based on factors such
as cancer site, cancer stage, and hospital resources. To estimate
this time, we used the findings from a previous study by
Bilimoria et al that calculate the time between diagnosis and
treatment [31]. Bilimoria et al examined 1,228,071 patient
records from 1995 to 2005 using data from the National Cancer
Database, which represents around 1443 hospitals in the United
States. Treatment waiting time was simulated using the (average;
minimum-maximum) days for the three cancer types. The
calculated values for breast, colorectal, and lung cancer were
(24; 14-40), (37; 20-63), and (26; 13-46), respectively [31]
(Multimedia Appendix 2). We also used the Cancer Facts and
Figures, 2012 to estimate the proportion of each cancer type at
the ISDH cancer registry (ISDH, 2012).
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Figure 4. Simulation model for the redesigned workflow.
Textbox 1. Estimated time for each reporting step.
Activity time (tasks performed by registrars)
• Task: Case finding from the pathology reports
• Time: Daily 1 hour
• Task: Case finding from the International Classification of Diseases-9 list
• Time: Monthly 1 day
• Task: Abstraction
• Time: Daily 45 min to 1.5 hours per case
Nonactivity time (waiting time)
• Phase: Suspense file
• Time: 3-6 months, varies among hospitals
• Phase: Completed cases reside at the local registry before submission
• Time: An average of 15 days for hospitals with higher caseloads (>300 cases per year)
Results
Overview
A total of 14 registrars agreed to participate, and the average
interview duration was 28 min (range 17-44 min). Half of the
participating registrars reported for larger hospitals (300 beds
and over). Out of the 14 registrars interviewed, 6 were reporting
for hospitals within Indianapolis and the others were reporting
for rural hospitals.
The interview focused on the following areas: (1) understanding
the workflow of cancer reporting, (2) estimating the time spent
on each phase within the process, and (3) identifying the barriers
to rapid reporting. The interview results were organized into
the existing workflow description and barriers, recommended
workflow, and simulation comparison.
JMIR Cancer 2018 | vol. 4 | iss. 1 | e4 | p.7http://cancer.jmir.org/2018/1/e4/
(page number not for citation purposes)
Jabour et alJMIR CANCER
XSL•FO
RenderX
Existing Workflow Description
Using the interview data, we mapped and described the existing
reporting workflow. The reporting process comprises 3 major
steps: case finding, abstraction, and reporting (Figure 1). The
details of each step are described below.
Step 1: Case Finding
When registrars were asked “how does reporting start?,” they
reported that the first step is case finding. This involves
identifying new cases of cancer that have been diagnosed within
a given period. This applies to all inpatients and outpatients
diagnosed with or treated for a reportable tumor. Registrars
reported that 90% to 95% of the reported cases are identified
through pathology reports. Pathology reports are especially
useful because they contain detailed information about the
cancer diagnosis, histology, and behavior. Some facilities use
additional sources for case finding, including hospital admission
and discharge records, surgery schedules, cytology reports,
oncology reports (medical and radiation), radiology reports, and
billing records. Participants suggested that those sources are
less informative than pathology reports. Nonetheless, registrars
often use multiple sources or refer to medical records to find
the information that they need. Data collected during case
finding may include demographic information and basic
information about the tumor such as site, histology, and
behavior. The amount of information collected at this stage is
subjected to the information availability and thus, may vary
from case to case. Missing information is often completed during
the abstracting phase, as the primary goal of case finding is the
identification of potentially reportable cases.
Once a case is confirmed as reportable, it is added to a suspense
file to await abstraction. In most facilities, case finding is
performed daily or weekly (for pathology reports) and monthly
(for all other sources). Cases may then reside in the suspense
file for several months before abstraction. The rationale for this
waiting period is to allow for tests and treatments to be
performed and thus, available for inclusion in the report
ultimately sent to public health authorities.
Step 2: Abstraction
Although case finding provides an initial awareness of a given
case, abstraction is more comprehensive and detailed.
Abstraction uses different parts of the medical record to collect
demographic information, tumor-related information, and
information about staging, diagnostic studies, and treatment.
When registrars were asked to describe the abstracting process,
we found that abstraction is less structured than case finding as
registrars flexibly use different parts of the medical record to
create a summary.
When registrars were asked, “where in the reporting cycle does
the delay exist?,” they reported that abstraction could be delayed
when data are not available in local medical records. This is
more frequent when patients receive care at an outside facility.
Registrars indicated that the percentage of cases that require
contacting external facilities varies widely, from 10% to 40%.
To access records at outside facilities, reporting registrars often
reach out to people at the hospitals where care was provided.
These individual contacts may range from health care providers
(eg, doctors or nurses) to cancer registrars working at the
external facilities. Once all the required information is collected
and the abstract is considered complete, it is then saved in
preparation for submission.
The interviews revealed that both case finding and abstracting
could be performed by the same registrar, especially at smaller
hospitals where the number of registrars is limited. Larger
hospitals, on the other hand, are more likely to divide the role
such that registrars can focus on either case finding or
abstracting.
Step 3: Submission
Registrars save the completed abstracts and send them in batches
to the state registry at fixed time intervals. The submission is
made electronically and takes less than 15 min for the entire
batch. Facilities with a higher number of cases are required to
report abstracts to the state registry at a higher frequency. For
example, the ISDH requires hospitals with an average of 1 to
59 cases annually to report their cases once each year; hospitals
with an average of 60 to 149 cases annually are required to
report their cases quarterly; hospitals with an average of 150 to
299 cases annually are required to report their cases every other
month; and hospitals with an average of 300 or more cases
annually are required to report them on a monthly basis.
Time per Step
We asked registrars to estimate the time it takes to perform each
task, and we aggregated the average time estimated (Textbox
1). During interview, we also asked registrars if they encounter
a delay or have to wait during the reporting process. The
interview results show that the reporting process cycle time
contains both activity and waiting times. The activity time
includes the time that registrars spend to access and retrieve
data, review the records, and enter information into the system.
Waiting time, on the other hand, refers to the time during which
cases or records reside in the system while no activities are
being performed. This includes the time that cases reside in a
suspense file before abstraction as well as the time that
completed reports reside in the local system before being sent
to the appropriate state registry.
Existing Workflow Barriers
We aggregated the barriers identified during the interview and
grouped them into the following themes. Most reported barriers
were related to data exchange, followed by information
quality-related barriers (Textbox 2).
Data Exchange
The most commonly reported barrier was accessing information
at external hospitals. Many of the facilities providing oncology
treatment are external or independent. Registrars reported that
the percentage of cases that requires contacting external facilities
varies from 10% to 40%. While describing the barriers
encountered, one interviewee stated:
Getting the information from physicians and letting
them know they are not breaking HIPPA if they give
us this information. Telling them even if we are not
face-to-face with the patients, we are still doing
patient care.
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Textbox 2. Summary of barriers reported by cancer registrars.
Theme: Data exchange
• Number of respondents: 8
• Key barriers identified:
• Difficulty accessing information within facilities outside the hospital network
• The lack of data exchange between electronic systems
Theme: Information quality
• Number of respondents: 6
• Key barriers identified:
• International Classification of Diseases codes are not sufficient for confirming the repeatability of the flagged cases
• Text reports using uncertain language such as “probable,” “suspected,” “likely,” “questionable,” and “possible”
• Different treating physicians sometimes report contradicting information
Theme: Information processing
• Number of respondents: 5
• Key barriers identified:
• Combine different events into a single coherent abstract
• Interpret some of the information in the medical records and translate it to fit the registry requirement
• Complicated cases with many procedures
• Large number of nonreportable cases that are flagged to be reviewed
Theme: Administrative tasks
• Number of respondents: 3
• Key barriers identified:
• Administrative tasks such as reviewing compliancy, serving on the tumor board and on cancer committees
• Reporting for other institutions with different reporting requirements such as Commission on Cancer
Theme: Technical factors
• Number of respondents: 2
• Key barriers identified:
• System session timeout
• Some systems do not have the ability to distinguish the previously reported cases from the new cases
Another interviewee stated:
I tend to go onsite and meet people. I don’t call a lot
because some places are not happy giving that
information. They want to know who I am and where
I am from, so the contact I do have, I build a rapport
with and I get the information from them.
When patients receive treatment at an external facility, the
abstracting registrar sometimes contacts the registrar working
for that facility instead of contacting the physicians or nurses.
This is often expressed as a preferable alternative, because they
are familiar with the reporting process and requirements. One
interviewee also stated that the real obstacle comes with finding
out where patients receive treatment, as this is not always
indicated in the medical records.
Another information exchange-related barrier was the system
inability to exchange information between departments within
the same hospital. An example of this would be hospitals that
use multiple systems such as legacy systems, paper-based
systems, or interoperable systems. One registrar stated that the
hospital system does not support some of the technology they
wish to use. Because the hospital system is not compatible with
the oncology management reporting system, registrars are not
able to use all of the features that require data sharing.
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Information Quality
Registrars reported some issues associated with physician’s
notes, such as the lack of information and the ambiguous
terminology. Most cancer diagnoses are confirmed through
biopsy, but when pathology reports are not available, other
information sources such as physician’s notes or diagnostic
imaging reports are used. The difficulty arises when uncertain
language is used. Terms such as “probable,” “suspected,”
“likely,” “questionable,” or “possible” lead registrars to seek
more data sources to confirm diagnosis.
A less common barrier identified during abstracting is
contradiction in the information found in the records. In some
rare cases, registrars find contradictions in the different
information sources, such as physician’s notes and pathology
reports or even within physician’s notes if multiple physicians
treat the same patient.
Information Processing
Registrars sometimes expressed some forms of mental load
while dealing with information. They collect information from
multiple sources and arrange them in chronological order,
building a series of events. One interviewee described it as
putting together pieces of a puzzle, where they try to find the
answer to what they are looking into. The sequence of events
has to follow a logical treatment path, using the available data.
This process can get complicated when some of the expected
events (such as treatment or procedures) are missing. Registrars
then will try to find out which data are missing or which
procedures were not performed. One registrar commented:
When you do that abstracting for patients you are
writing their story, you are the author. You want to
make sure you have all the facts, the dates, the
treatment collection, date of birth, name, so when you
write, your comments have to be clear as to what
happened to that patient.
The second factor that contributes to the mental load is the
interpretation of the physician’s note. Terminology used may
differ from that which is required by the central registries.
Interpreting this information requires not only a solid
understanding of the domain but also an understanding of the
patient’s individual situation and contexts. This can be more
challenging for complicated cases with many procedures.
An additional challenge can be presented when using
International Classification of Diseases (ICD) codes for case
finding. During case finding, registrars search the hospital
database for the predetermined set of codes and keywords that
may indicate a tumor. This may result in many nonreportable
cases also being retrieved by the system. Registrars indicated
that only 2.5% to 11% of the cases identified through disease
indices are reportable. To filter them, registrars manually review
the results to verify their eligibility for reporting.
Administrative Tasks
Some registrars indicated that administrative tasks, such as
reviewing compliancy and serving on a tumor board and on
cancer committees, could be time-consuming. In addition to
reporting to state registries, some hospitals voluntarily report
to the Commission on Cancer (CoC), which requires continuous
follow-up. This involves updating the patient status, cancer
status, any recurrence, new cancer, or new treatments. To
perform the follow-up, registrars continue searching and
updating patients’ information for life. When describing the
follow-up required by CoC, one registrar stated:
Going through 3000 plus in the suspense file and only
getting 300 or 50 in my case. That is a huge
time-consuming part.
Technical Factors
Registrars collect information from diverse sources, which
requires them to access different systems, paper records, or
make phone calls. Being busy with one source will result in
inactivity in the previous one, and most electronic systems will
log the user out automatically if being inactive for certain period
of time. One registrar commented:
My most time-consuming thing for me lately is getting
the medical records to work...logging to the system,
staying logged in, dealing with connection.
Other barriers were software-related. Some registrars indicated
that open source software, such as Rocky Mountain, only
provide the basic features and do not provide any of the
additional functionalities that can promote an efficient workflow,
especially for matching cases and case follow-up.
Workflow Recommendations
The redesign focused on the deviations that could have the
highest impact on the reporting time (Textbox 3). On the basis
of the respondents’ feedback, time spent on cancer reporting
comprises not only the time spent on tasks but also waiting time,
which consumes most of the total reporting time (Textbox 1).
Most of this waiting time occurs while patients await treatments
and procedures. Respondents further indicated that the time
cases reside in suspense files vary between facilities, but the
same waiting time is applied to all cases within a given facility.
Registrars agreed that procedures and treatments could be
performed at different speeds, depending on many factors such
as cancer type, cancer stage, and facility resources. This
variation suggests that using a standard waiting time for all
cases creates an unnecessary delay if treatments are delivered
earlier than the anticipated time. We recommend using a
notification system (described below) to target this phase of
reporting due to its higher impact on timeliness relative to the
other phases (Textbox 1). Moreover, cancer registrars reported
that data exchange and access to external records was a major
barrier during abstraction. On the basis of impact and
pervasiveness, we recommend incorporating an electronic
pathology reporting system (ePath) for case finding, access to
HIE networks, and secure messaging systems (Textbox 3).
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Textbox 3. Barriers addressed by recommendations.
Recommendation: Electronic pathology reporting system
• Barrier theme: Information processing
• Specific example: Over 90% of the cases identified during case finding are identified through pathology reports
Recommendation: Notification system
• Barrier theme: Not applicable
• Specific example: Waiting time in the suspense file: cases may take up to 6 months after case finding to abstracting
Recommendation: Access to health information exchange
• Barrier theme: Data exchange
• Specific example: Difficulty accessing information within facilities outside the hospital network
• Barrier theme: Information processing
• Specific examples:
• International Classification of Diseases codes are not sufficient for confirming the repeatability of the flagged cases
• Text reports using uncertain language such “probable,” “suspected,” “likely,” “questionable,” and “possible”
Recommendation: Messaging system
• Barrier theme: Data exchange
• Specific example: Difficulty accessing information within facilities outside the hospital network
Electronic Pathology Reporting System
About 90% to 95% of cases identified at the case finding stage
are identified through pathology reports. Using an ePath system
for case finding has been shown to improve reporting timeliness
and increase reporting efficiency [32]. Many registrars stated
that they had automated the process of case finding from
pathology reports and adopted the Public Health Information
Network Messaging System for sending Health Level Seven
(HL7) messages [32-34].
Notification System
We propose adding a notification system between the hospital
cancer data management system and the EHR system to notify
registrars when new treatments are delivered. Using a
notification system would enable registrars to abstract a given
case as soon as new treatment data are added to the hospital
EHR system instead of the current method, which applies the
same waiting time for all cases. Notification systems for
workflow optimization have been applied in other health care
settings to promote the coordination of care [35]. System
notification can be implemented using HL7 Clinical Document
Architecture notification messages. Once a new treatment is
added to the EHR system, an event can be triggered and the
notification system will match it with patient lists in the suspense
file. If a match is found, then registrars can be notified about
the addition of the new treatment.
Access to Health Information Exchange
Indiana hospitals have participated in the Indiana HIE for more
than a decade [36,37], yet the exchange does not currently
facilitate access for cancer registrars. Utilizing the existing HIE
network to facilitate access to information could reduce obstacles
to obtaining details about cancer cases and outcomes. Moreover,
accessing more information can also improve the accuracy of
reporting. Several other states also have an HIE infrastructure
that could be similarly utilized. Studies have shown the benefits
of HIEs in improving access to clinical data [38-43].
Secure Messaging System
Our result shows that registrars encounter difficulties when
asking clinicians at external facilities for patient information.
As a result, they contact the registrars at the external facilities
to access patient information. This relationship was perceived
as more conducive to accessing the information needed, given
their understanding of each other’s job role and reporting
requirements. In this workflow model, we propose the usage of
a secure messaging system to facilitate communication among
registrars so as to minimize the access barriers to the sharing
of information. Studies have shown that the use of secure
messaging in other clinical settings improves communication
effectiveness among health professionals [44].
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Table 1. Comparison of existing and proposed methods simulations.
Simulation timeWorkflow design
2 years1 year
Existing workflow
102.2, 138.6, 180.6102.2, 138.6, 177.8Days (minimum, average, maximum)
128.9, 149.1128.9, 149.1Percentile (25%, 75%)
10.710.8Standard deviation
Recommended workflow
19.6, 51.8, 95.219.6, 51.8, 95.2Days (minimum, average, maximum)
39.5, 61.939.5, 61.9Percentile (25%, 75%)
9.810.2Standard deviation
<.001.039P value at 95% CI
Recommended Workflow Steps
Figure 2 shows the flowchart for the redesigned workflow. The
steps for the redesigned workflow are as follow:
1. Cancer cases are identified through pathology reports using
the ePath system.
2. Registrars review and approve cancer cases identified by
ePath.
3. Registrars perform case finding manually for the other data
sources.
4. Cases identified as reportable are saved in the suspense file
for abstraction. A copy of the identified cases is sent to the
state registry and marked as incomplete.
5. EHR sends a notification to the cancer registry management
system regarding the delivery of any new cancer-related
treatment. If the notification matches any of the cases in
the suspense file, then the case will be flagged.
6. The registrar will check the flagged case and start
abstracting. If no new treatment is received within 6 months
of the date of diagnosis, then the registrar will start
abstracting and check the physician’s notes and discharge
summaries regarding whether treatment was provided
elsewhere.
7. If treatment is received at an outside facility, then registrars
will use the HIE to search for external information.
8. If more information is needed, then the reporting registrar
can use the secure messaging system to contact other
registrars at the outside facility.
9. Registrars save the completed abstracts in the local database
to be reported at fixed intervals.
Simulation Output
The simulation results show that the redesigned workflow could
potentially reduce the reporting time from an average of 138
days to 51 days (Table 1). Although the redesigned workflow
added new tasks to minimize some of the barriers identified
during interview, most of the reduction in reporting time was
attributed to simulating the notification system. Although most
tasks take an hour or less, waiting in the suspense file may take
up to 6 months (Textbox 1). As seen in our simulation
assumption (Multimedia Appendix 2), simulating the notification
system enables us to distinguish the time that cases reside in
the suspense file among the three cancer types.
Discussion
Principal Findings
There is an increasing interest in leveraging cancer registry data
to advance the quality of cancer care and bridge the gap between
scientific discovery and existing practice [1-4]. Yet, the lengthy
reporting time is a major challenge that inhibits the use of cancer
registry data for actionable intervention [1-4]. Little is known
about the cancer reporting process or the barriers encountered
during reporting. In this study, we conducted key informant
interviews to understand the details of the reporting process and
workflow activities at the hospital level. We examined the time
taken at each stage of reporting to target the most
time-consuming activities and shorten the reporting process.
Prior research has applied data mining and machine learning
techniques to simplify case finding activities and enable
automated identification of cancer cases. Although this approach
can minimize the time spent on these activities, we found that
cancer reporting processes comprise not only active tasks
performed by registrars but also inactive waiting times, during
which registrars wait for new information about cancer cases
to become available in the EHR. These waiting periods occur
during the interval of time wherein patients receive diagnostic
procedures and treatment. Our findings suggest that the waiting
periods can consume more of the total time associated with
cancer case reporting than those periods involving active tasks
performed by registrars. Consequently, timeliness may be
improved by changing the queuing method that is currently
applied by registers across hospital types.
Cases generally reside in a suspense file at the hospital for a
few months, during which time treatments and procedures are
delivered by clinicians and subsequently entered into the
hospital’s EHR system. Thus, the first case entered into the
suspense file will be the first case abstracted later when the
registrar checks for updates. However, procedures and
treatments are scheduled and performed at various speeds,
depending upon factors such as the cancer type, stage, facility
resources [31], as well as other social and clinical patient
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characteristics. Using a standard waiting time for all cases
creates an unnecessary delay if treatments are delivered earlier
than anticipated. Adding automated EHR-based notification
mechanisms, to inform registrars when new data are available,
will enable cancer registrars to abstract case information as soon
as it is available instead of waiting a fixed period of time for all
cases.
Using EHR-based notification mechanisms could also be applied
with two-phase reporting. Two-phase reporting could support
the development of “Rapid Learning Systems” [45] where cases
can be reported as an incomplete abstract after case finding and
updated once treatment and outcome data become available.
Technology-enhanced methods will further enable surveillance
for timely and high-quality treatment by alerting registrars (or
clinicians) when individuals diagnosed with cancer may be
overdue for treatment or have been lost to follow-up.
Limitations
One methodological limitation of our study is the absence of
field observations to complement the semistructured interview
data, as well as a more quantitative assessment of the prevalence
of various barriers through structured surveys. Yet, an advantage
of the cancer registrar interviews was the ability to capture rich,
in-depth descriptions of a broad range of processes involved in
end-to-end cancer reporting. Self-reported interview data are
subject to recall bias; however, this threat to validity is lessened
by the fact that registrar descriptions generally agreed with one
another. We also limited the interviews to experts who could
provide insight into the process by focusing on certified
registrars who currently report to the ISDH cancer registry.
Moreover, we included both large and small hospitals, as well
as urban and rural hospitals, to enhance the generalizability of
our results.
A second limitation is the method for estimating the simulation
input for the redesigned workflow. To conduct the simulation
for the redesigned workflow, we needed an estimate of the
expected time that cases reside in the suspense file. This is
represented by the time from case finding to availability of
treatment results. To estimate this time, we used a national study
that measured the time from diagnosis to treatment [31].
Although this approach could underestimate the simulation
input by disregarding the extra time needed to document the
treatment result and add it to the EHR, it could also overestimate
the simulation input by disregarding the shortened period for
case finding likely to occur with implementation of the ePath
system.
Currently, cancer registrars can begin abstraction at the start of
the first course of treatment; however, registrars may decide to
wait longer to have more complete treatment information to
add. For future research, we recommend measuring the time
from diagnosis to treatment using the treatment data available
at the registry to estimate the minimum reporting time possible
for a given rate of completion.
Moreover, our study was limited to cancer registrars within the
state of Indiana. Although most state registries have similar
reporting requirements and training, we believe evaluating the
reporting process in other states will be important to assess the
generalizability of our results and recommendations.
Conclusions
Key barriers to the rapid collection of cancer surveillance
information in the existing reporting process include data
residing at multiple institutions and the waiting period for the
completion of treatment. Our results highlight how health
information technologies could be leveraged to overcome these
barriers, including ePath systems, HIE, and secure messaging.
Understanding the time elapsing at each step within the process
helps in prioritizing the needs and estimating the impact of
future interventions.
In this study, we discovered that reporting speed cannot be
entirely controlled by accelerating the case finding or the
abstraction process. Pragmatically speaking, registrars need to
wait for treatments and procedures to be performed and entered
into the EHR before collecting the data. Appropriate waiting
intervals could be better defined by further exploring how much
the time from diagnosis to treatment varies for different cancer
types. Understanding this variation could help determine the
potential value of implementing a notification system, as well
as setting reasonable expectations for reporting time by cancer
type.
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